Kiniksa CEO granted 120K options, 30K RSUs

KNSA’s chairman and CEO received new RSU and option grants, while vested RSUs were converted into shares held by affiliated trusts with some shares withheld at $79.28 per share.

Rhea-AI Filing Summary

Kiniksa Pharmaceuticals International, plc (KNSA) reported that chairman and CEO Sanj K. Patel received equity awards on September 1, 2026. He was granted 30,050 Restricted Share Units, each representing one Class A Ordinary Share, and 120,150 share options with an exercise price of $79.28 per share expiring on August 31, 2036. On the same date, several previously granted Restricted Share Units vested and were converted into Class A Ordinary Shares held indirectly through The Patel Family Irrevocable Trust of 2025, with 15,144 shares delivered or withheld to cover the exercise price or tax liability at $79.28 per share. Indirect holdings also include 109,795 Class A Ordinary Shares held by The Marina 2016 Irrevocable Trust and 51,794 Class A Ordinary Shares held by The Anglia 2013 Revocable Trust. No Rule 10b5-1 trading plan is reported for these transactions.

Insider Trade Summary

31,318 shares exercised/converted

Exercise 13 txns

Insider Patel Sanj K

Role CHAIRMAN & CEO

Type	Security	Shares	Price	Value
Grant/Award	Restricted Share Unit F1, F2	30,050	$0.00	$0.00
Grant/Award	Share Option F3	120,150	$0.00	$0.00
Exercise	Restricted Share Unit F1, F4	8,609	$0.00	$0.00
Exercise	Restricted Share Unit F1, F5	6,237	$0.00	$0.00
Exercise	Restricted Share Unit F1, F6	6,481	$0.00	$0.00
Exercise	Restricted Share Unit F1, F7	9,991	$0.00	$0.00
Exercise	Class A Ordinary Share F1	9,991	--	--
Exercise	Class A Ordinary Share F1	6,481	--	--
Exercise	Class A Ordinary Share F1	6,237	--	--
Exercise	Class A Ordinary Share F1	8,609	--	--
Exercise Price or Tax Liability	Class A Ordinary Share	15,144	$79.28	$1.20M
holding	Class A Ordinary Share	--	--	--
holding	Class A Ordinary Share	--	--	--

Holdings After Transaction: Restricted Share Unit — 74,832 contracts (Direct); Share Option — 120,150 contracts (Direct); Class A Ordinary Share — 92,348 shares (Indirect, Held by The Patel Family Irrevocable Trust of 2025); Class A Ordinary Share — 109,795 shares (Indirect, Held by The Marina 2016 Irrevocable Trust, u/d/t June 23, 2016); Class A Ordinary Share — 51,794 shares (Indirect, Held by The Anglia 2013 Revocable Trust, u/d/t August 15, 2013)

Footnotes (7)

1. F1. Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.
2. F2. The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2026.
3. F3. The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2026.
4. F4. The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2025.
5. F5. The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2024.
6. F6. The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023.
7. F7. The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022.

Key Figures

New RSU grant: 30,050 units New option grant: 120,150 options Option exercise price: $79.28 per share +4 more

7 metrics

New RSU grant 30,050 units Restricted Share Units granted to Sanj K. Patel on September 1, 2026

New option grant 120,150 options Share options for Class A Ordinary Shares granted on September 1, 2026

Option exercise price $79.28 per share Exercise price of options expiring August 31, 2036

Shares delivered/withheld for exercise price or taxes 15,144 shares Class A Ordinary Shares used to cover exercise price or tax liability at $79.28 per share

Indirect Marina Trust holdings 109,795 shares Class A Ordinary Shares held by The Marina 2016 Irrevocable Trust as of September 1, 2026

Indirect Anglia Trust holdings 51,794 shares Class A Ordinary Shares held by The Anglia 2013 Revocable Trust as of September 1, 2026

RSUs exercised into shares (largest block) 9,991 units Largest single block of Restricted Share Units converted into Class A Ordinary Shares on September 1, 2026

Key Terms

Restricted Share Unit, Class A Ordinary Share, exercise price, irrevocable trust

4 terms

Restricted Share Unit financial

"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."

A restricted share unit (RSU) is a promise by a company to give an employee a set number of company shares at a future date, typically after meeting time or performance conditions. For investors, RSUs matter because when they convert into actual shares they increase the number of shares outstanding (like unlocking more tickets in a game), which can dilute existing holders, and they align employee incentives with company performance, influencing behavior and long-term value.

Class A Ordinary Share financial

"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."

A Class A ordinary share is a type of common stock a company issues that carries a specific set of rights—most often particular voting power, dividend terms, or transfer rules—distinct from other share classes. For investors it matters because those rights affect control over company decisions, how income is paid out, and how easy shares are to buy or sell; think of it like a tiered ticket that gives different access and influence at the same event.

exercise price financial

"The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter."

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

irrevocable trust financial

"Held by The Patel Family Irrevocable Trust of 2025"

An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.

FAQ

What new equity awards did KNSA grant to its CEO Sanj K. Patel on September 1, 2026?

On September 1, 2026, Sanj K. Patel received a grant of 30,050 Restricted Share Units and 120,150 share options for Class A Ordinary Shares with an exercise price of $79.28 per share, expiring on August 31, 2036.

How do the new KNSA RSUs granted to the CEO vest?

The new Restricted Share Units granted to Sanj K. Patel on September 1, 2026 vest over four years, with 25% of the RSUs vesting on each yearly anniversary of the grant date, beginning on September 1, 2026.

What are the vesting terms of the new KNSA share options granted to the CEO?

The share options granted to Sanj K. Patel vest as to 25% of the total grant on the first anniversary of the vesting commencement date, then in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2026.

How many KNSA shares were withheld or delivered to cover the exercise price or taxes?

On September 1, 2026, 15,144 Class A Ordinary Shares associated with Sanj K. Patel’s indirect holdings were delivered or withheld to cover the exercise price or tax liability at $79.28 per share.

Were the KNSA insider transactions on September 1, 2026 made under a Rule 10b5-1 plan?

No. The filing indicates that no Rule 10b5-1 trading plan is reported for the transactions by Sanj K. Patel on September 1, 2026.

What KNSA shares are held by trusts associated with the CEO after these transactions?

After the reported transactions, indirect holdings include 109,795 Class A Ordinary Shares held by The Marina 2016 Irrevocable Trust and 51,794 Class A Ordinary Shares held by The Anglia 2013 Revocable Trust, in addition to shares held by The Patel Family Irrevocable Trust of 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/03/2026 - 05:01 PM Accepted by SEC EDGAR 09/03/2026 - 04:46 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Patel Sanj K

(Last) (First) (Middle)

C/O KINIKSA PHARMACEUTICALS INT'L

105 PICCADILLY, SECOND FLOOR

(Street)

LONDON W1J 7NJ

(City) (State) (Zip)

UNITED KINGDOM

(Country)

2. Issuer Name and Ticker or Trading Symbol
Kiniksa Pharmaceuticals International, plc [ KNSA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHAIRMAN & CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Ordinary Share	09/01/2026		M		9,991	A	(1)	86,165	I	Held by The Patel Family Irrevocable Trust of 2025
Class A Ordinary Share	09/01/2026		M		6,481	A	(1)	92,646	I	Held by The Patel Family Irrevocable Trust of 2025
Class A Ordinary Share	09/01/2026		M		6,237	A	(1)	98,883	I	Held by The Patel Family Irrevocable Trust of 2025
Class A Ordinary Share	09/01/2026		M		8,609	A	(1)	107,492	I	Held by The Patel Family Irrevocable Trust of 2025
Class A Ordinary Share	09/01/2026		F		15,144	D	$79.28	92,348	I	Held by The Patel Family Irrevocable Trust of 2025
Class A Ordinary Share								109,795	I	Held by The Marina 2016 Irrevocable Trust, u/d/t June 23, 2016
Class A Ordinary Share								51,794	I	Held by The Anglia 2013 Revocable Trust, u/d/t August 15, 2013

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Share Unit	(1)	09/01/2026		A		30,050		(2)	(2)	Class A Ordinary Share	30,050	$0	30,050	D
Share Option	$79.28	09/01/2026		A		120,150		(3)	08/31/2036	Class A Ordinary Share	120,150	$0	120,150	D
Restricted Share Unit	(1)	09/01/2026		M			8,609	(4)	(4)	Class A Ordinary Share	8,609	$0	25,826	D
Restricted Share Unit	(1)	09/01/2026		M			6,237	(5)	(5)	Class A Ordinary Shares	6,237	$0	12,475	D
Restricted Share Unit	(1)	09/01/2026		M			6,481	(6)	(6)	Class A Ordinary Share	6,481	$0	6,481	D
Restricted Share Unit	(1)	09/01/2026		M			9,991	(7)	(7)	Class A Ordinary Share	9,991	$0	0	D

Explanation of Responses:

1. Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

2. The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2026.

3. The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2026.

4. The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2025.

5. The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2024.

6. The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023.

7. The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022.

	/s/ Douglas Barry, Attorney-in-Fact	09/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)